Key facts
- This page summarizes Lucy Lu's Form 4 filing for AVENUE THERAPEUTICS, INC. (ATXI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2021, 16:08.
Lucy Lu - 17 Dec 2021 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)
- Reporting relationship
- President, CEO, Director
- Issuer ticker
- ATXI
- Reported as of
- 17 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2021, 16:08:30 UTC
- Prior SEC filing
- 05 Nov 2021
- Next SEC filing
- 04 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lucy Lu, M.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lucy Lu filed Form 4 for AVENUE THERAPEUTICS, INC. (ATXI) on 20 Dec 2021.
Change
- Previous filing in this sequence was filed on 05 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATXI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +411,616
- Change %
- +122%
- Price
- $0.000000
- Shares after
- 748,949
- Date
- 17 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This restricted stock unit award (RSU) vests on March 15, 2022. Each restricted stock unit is equivalent to one share of the Company's common stock.
Footnote F2
Includes 411,616 RSUs.